WEAK BUY
Industrials have been slammed and CHE just settled a lawsuit, so this will be punished until the final settlement. Balance sheet is merely okay. But this is cheap now. Safe, high dividend. They could sell assets to help their balance sheet. It's messy but you can buy it at these levels.
COMMENT
Q3 beat--earnings were way up. Double-digit growth in the US. Asia operations were a lower weak. 4% EPS growth only. Pricey vs. peers. Manulife has a better growth rate, and he prefers MFC. The lawsuit they face--MFC will be okay.
BUY
vs. Sunlife Q3 beat--earnings were way up. Double-digit growth in the US. Asia operations were a lower weak. 4% EPS growth only. Pricey vs. peers. Manulife has a better growth rate, and he prefers MFC. The lawsuit they face--MFC will be okay.
TOP PICK
Q3 was a very big beat and they are seriously growing their earnings. Funds from operation per share were way up, and he forecasts 10% growth there. As long as they execute and interest rates don't skyrocket, this stock will work. (Analysts’ price target is $69.25)
TOP PICK
Their Q3 beat by 10% and raised guidance as well as dividend. Well-run. He expects them to deploy $6-8 billion in coming years to drive growth. Will grow earnings 30% annually. Trades at only 13x. Solid dividend and balance sheet. (Analysts’ price target is $84.64)
TOP PICK
Funding remains a problem: will they have to dilute shares? Also, it's a yield proxy, so what happens as interest rates rise? Pays a nice, safe dividend. Cheap at 13.3x times with a good balance sheet. They'll grow their earnings. It's shelter from the current storm. (Analysts’ price target is $63.91)